It remained to be studied if the prognostic significance of high IL2RA mRNA expression in CBF AML is associated with gene mutations involved in activating tyrosine kinase signaling other than FLT3-ITD or c-KIT D816V mutation, or with other mechanisms. The gene discussed is IL2RA; the disease is acute myeloid leukemia.